MCS ADVISORY

Boutique healthcare advisory.
Operator-grade finance.

Healthcare M&A, Capital Raises, and Investment Analysis. Plus Defense & Federal Healthcare and Fractional CFO services. We work with PE-backed healthcare platforms, family offices, independent multispecialty surgery centers, group practices, and biotech founders preparing for capital events.

Confidential conversation
Tampa, FL · Veteran-Owned · Founder of CatalystIQ
Medical office and surgery center building
Twelve turnkey ASCs delivered. 200,000+ square feet of medical and surgery center space developed. 140,000+ procedures overseen.

Thirteen-plus years building, financing, and operating private-sector healthcare ventures across PE-backed holding companies, family-office investments, multispecialty Ambulatory Surgery Centers, multi-site group practices, behavioral health platforms, and biotech ventures.

Current book includes
  • Non-equity Operating Partner at a healthcare holding company — leading the VC raise plan build
  • Seed-stage VC raise for a behavioral health platform — currently in market
  • Multispecialty ASC physician-investor syndication — Dallas-Fort Worth partnership
  • Biotech institutional research for family-office investors (DCF + rNPV via CatalystIQ)

Operational backbone: 23-year US Army Medical Service Corps career, retired as Lieutenant Colonel in 2012. As Ops Officer for JTF CAPMED NCR, operations officer in the $1.5B DoD healthcare consolidation that merged three teaching hospitals and realigned 48 clinics under SecDef-reporting Joint Task Force, supporting 439,000 TRICARE beneficiaries and 9,600 staff. That operating discipline informs how MCS Advisory approaches M&A integration, multi-site consolidation, and capital event preparation.

Legion of Merit · Bronze Star · Defense Meritorious Service Medal · Combat Action Badge · Expert Medical Badge · Order of St. George (peer-nominated)
If any of these sound familiar

Where we work.

We engage where the financial and operational stakes are real. Recent engagements have started with one of these conversations.

"We need to raise capital but don't have the pitch."
Healthcare and biotech founders preparing for seed through Series B raises who need a real pitch deck, financial model, and investor data room. → Transaction Advisory
"Our DSO is above 55 days and cash is tight."
Multi-location practices stuck above 50-day DSO, leaking 15–25% of receivables. We have brought practices from 65 → 42 days with $3M+ annual cash flow improvement in six months. → Fractional CFO
"We need a senior healthcare CFO but can't justify the FTE."
Practices and platforms in the $2M–$100M revenue range that need executive-level finance leadership but cannot yet support a full-time CFO. → Fractional CFO
"We have a biotech position and don't know how to underwrite it."
Family offices and individual investors who need institutional-grade DCF and rNPV analysis on biotech equity positions, calibrated against actual M&A comparables. → Investment Analysis
"Our MSO rollup is blowing past the integration timeline."
PE-backed platforms mid-rollup with stalled accounting consolidation, payor contracting gaps, or PC-structure compliance issues. We bring the integrated finance / legal / accounting bench. → MSO Services
"Our ASC project has stalled in licensure."
Projects that miss state plan review, blow past CON timelines, or hit Medicare certification delays. We have shepherded twelve turnkey ASCs through licensure and accreditation. → ASC Development
Current Book

Selected active engagements.

Disclosed at the category level. All client-identifying details treated as confidential.

  • Behavioral health platform — seed-stage VC raise, in market
  • Healthcare holding company — operating partner, VC raise plan build
  • Multispecialty ASC syndicate — DFW physician-investor partnership
  • Biotech institutional research — DCF + rNPV (CatalystIQ)
$100M+
Commercial revenue cycles managed
12
Turnkey ASCs delivered concept through accreditation
200,000+
Sq ft of medical and ASC space developed
140,000+
ASC procedures overseen across specialties
$15M+
Client capital secured through VC raises and financing
$1.5B
DoD healthcare consolidation (founder's service)
Accreditation & Compliance Expertise
MEDICARE Certification · AAAHC · ACHC · Joint Commission · HIPAA & HITECH · Stark & AKS
Coming July 2026

CatalystIQ — institutional-grade biotech research, $14.99/month.

An AI-powered biotech and macro research terminal for individual investors and family offices who want institutional-grade analysis without paying $30K per year for a Bloomberg terminal. DCF, rNPV, Monte Carlo simulation, AI-generated Earnings Insight reports, comparable M&A transactions database. Free tier plus $14.99 / month Pro (or $149 / year).

Visit CatalystIQ
S&P 500 5,480 +0.4%
NASDAQ 100 19,200 +0.6%
FWD P/E 19.9
10Y YIELD 4.28%
VIX 21.4
SECTOR · ENERGY +12.6%
SECTOR · IT -8.2%
SENTIMENT CAUTIOUS
How We Think

Operators who do real finance. Not finance people guessing at operations.

MCS Advisory sits at the intersection of operator and finance — military leadership background, MBA plus dual master's, 10+ years running ASCs and physician practices, equity-research methodology. The same analytical rigor a Sanofi BD team would run on an acquisition target, applied to the practices, platforms, and positions you actually hold.

Track Record · Public Validation
Our Esperion (ESPR) conservative valuation note projected fair value at $3.01–$3.50 over a Q3–Q4 2026 horizon. On May 1, 2026, Archimed acquired Esperion at $3.16 per share — within 5% of our Q3 target.
Published Q1 2026. Vindicated May 2026. Same methodology powers CatalystIQ — public launch July 2026. View research →
Common Questions

What buyers ask before they engage us.

What does a fractional CFO engagement with MCS Advisory cost? +

Fractional CFO engagements typically run from $8,000–$25,000 per month depending on the practice size, complexity, and time commitment required. Most engagements are six-month minimums with month-to-month after that. We scope every engagement letter to the specific deliverables — DSO reduction targets, FP&A cadence, capital event preparation, board reporting — so you know exactly what you are paying for.

How long does ASC development typically take? +

From feasibility assessment to first Medicare-certified case, most turnkey ASC projects take 14–22 months. The variables: Certificate of Need (CON) status in your state, build-out vs. ground-up construction, single-specialty vs. multi-specialty complexity, and the speed of physician-investor syndication. We sequence projects to hit accreditation surveys with case volume already committed.

Do you work with PE-backed platforms and family offices? +

Yes. Roughly half of our current book is PE-backed platforms and family-office-backed healthcare ventures. We are typically engaged for MSO architecture, multi-site integration support, fractional executive leadership, and pre-exit financial preparation. References available upon request after initial qualifying conversation.

What is the minimum engagement size? +

Project-based engagements start around $15,000 (e.g., a single financial model, a focused investment thesis, or a fractional CFO assessment). Fractional retainer engagements start at $8,000 / month. Single-day strategy sessions and emergency triage work are scoped separately when the situation requires it.

How are you different from a traditional consulting firm? +

Traditional consulting firms send analysts and produce slide decks. We send senior principals — the only people who work on your engagement are the ones whose names appear on this site. Kays as Managing Partner leads every engagement. Noel C. Pace joins where healthcare law or regulatory work is required. Adam joins for accounting consolidation and ERP integration. No leverage model, no two-by-two matrices, no manufactured insights. You get the operator who has actually done what you need to do.

Do you only work with Tampa-area clients? +

No. We are based in Tampa, Florida but engage with clients across the United States. Current engagements span Florida, Texas (DFW ASC syndicate), and several family-office relationships with national scope. For ASC development and on-site fractional CFO work, we travel to client sites as needed.

Strategic Insights

Receive our research notes.

Healthcare M&A intelligence, biotech investment notes, ASC and MSO market analysis, and CatalystIQ research previews. Sent when we publish — never more than twice a month.

Confidential. Unsubscribe anytime. We do not share, sell, or syndicate the list.

Let's talk

Confidential conversations.

Founders preparing for capital events, healthcare holding companies, family offices and institutional investors, multispecialty ASCs and group practices, and physician practices that need cash-flow CFO work. Every initial conversation is with Kays directly.

Request a confidential conversation